Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

NCT03658330 is registered in ClinicalTrials.gov with VA Connecticut Healthcare System as lead sponsor.

NCT NCT03658330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03658330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
Lead sponsor
VA Connecticut Healthcare System
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
June 30, 2018
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, major depressive disorder